Smith Group Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Smith Group Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$21M	Sell	35,483 -730	-2%	-$419K	1.11%	34
2021 Q4	$24.1M	Sell	36,213 -1,321	-4%	-$825K	1.11%	34
2021 Q3	$21.5M	Sell	37,534 -21,019	-36%	-$11.5M	1.09%	35
2021 Q2	$29.6M	Sell	58,553 -6,810	-10%	-$3.21M	1.45%	22
2021 Q1	$29.8M	Buy	65,363 +2,207	+3%	+$1.05M	1.58%	23
2020 Q4	$29.5M	Buy	63,156 +32,236	+104%	+$15.1M	1.71%	19
2020 Q3	$13.7M	Buy	+30,920	New	+$12.8M	0.71%	41

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Smith Group Asset Management's TMO Position: Q1 2022 in Review

Smith Group Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 2% in Q1 2022, selling an estimated $419K and leaving 35,483 shares worth $21M. The position accounts for 1.11% of the portfolio, ranked #34.

Smith Group Asset Management first reported a position in TMO in Q3 2020 and has held it in 7 quarters since. The position peaked at $29.8M in Q1 2021. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

Smith Group Asset Management held 35,483 shares of Thermo Fisher Scientific worth $21M as of Q1 2022.
Smith Group Asset Management sold 730 Thermo Fisher Scientific shares in Q1 2022, an estimated $419K.
Thermo Fisher Scientific made up 1.11% of Smith Group Asset Management's portfolio in Q1 2022, its #34 holding.
Smith Group Asset Management first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 7 quarters since.
Smith Group Asset Management's Thermo Fisher Scientific position peaked at $29.8M in Q1 2021.
2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Smith Group Asset Management's 13F filing for Q1 2022, filed 5 May 2022.